Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.
Neven
N
N
Vis
M
M
Voskuyl
A E
AE
Wolbink
G J
GJ
Nurmohamed
M T
MT
Dijkmans
B A C
BA
Lems
W F
WF
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D009894:Opportunistic Infections / Q000139:chemically induced; D011446:Prospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab